0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Equine Chorionic Gonadotropin (eCG) for Injection Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-4Q17283
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Equine Chorionic Gonadotropin eCG for Injection Market Research Report 2024
BUY CHAPTERS

Global Equine Chorionic Gonadotropin (eCG) for Injection Market Research Report 2026

Code: QYRE-Auto-4Q17283
Report
2026-04-10
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Equine Chorionic Gonadotropin (eCG) for Injection Market Size

The global Equine Chorionic Gonadotropin (eCG) for Injection market was valued at US$ 280 million in 2025 and is anticipated to reach US$ 388 million by 2032, at a CAGR of 4.8% from 2026 to 2032.

Equine Chorionic Gonadotropin (eCG) for Injection Market

Equine Chorionic Gonadotropin (eCG) for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Equine Chorionic Gonadotropin (eCG) for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. The action of eCG is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The North American market for Equine Chorionic Gonadotropin (eCG) for Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Equine Chorionic Gonadotropin (eCG) for Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection include MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Equine Chorionic Gonadotropin (eCG) for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Equine Chorionic Gonadotropin (eCG) for Injection. The Equine Chorionic Gonadotropin (eCG) for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Equine Chorionic Gonadotropin (eCG) for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Equine Chorionic Gonadotropin (eCG) for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Equine Chorionic Gonadotropin (eCG) for Injection Market Report

Report Metric Details
Report Name Equine Chorionic Gonadotropin (eCG) for Injection Market
Accounted market size in 2025 US$ 280 million
Forecasted market size in 2032 US$ 388 million
CAGR 4.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 1000 IU/Unit
  • 5000 IU/Unit
  • Others
by Application
  • Pig
  • Cattle
  • Sheep
  • Horse
  • Other Animals
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Equine Chorionic Gonadotropin (eCG) for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Equine Chorionic Gonadotropin (eCG) for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Equine Chorionic Gonadotropin (eCG) for Injection Market growing?

Ans: The Equine Chorionic Gonadotropin (eCG) for Injection Market witnessing a CAGR of 4.8% during the forecast period 2026-2032.

What is the Equine Chorionic Gonadotropin (eCG) for Injection Market size in 2032?

Ans: The Equine Chorionic Gonadotropin (eCG) for Injection Market size in 2032 will be US$ 388 million.

Who are the main players in the Equine Chorionic Gonadotropin (eCG) for Injection Market report?

Ans: The main players in the Equine Chorionic Gonadotropin (eCG) for Injection Market are MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical

What are the Application segmentation covered in the Equine Chorionic Gonadotropin (eCG) for Injection Market report?

Ans: The Applications covered in the Equine Chorionic Gonadotropin (eCG) for Injection Market report are Pig, Cattle, Sheep, Horse, Other Animals

What are the Type segmentation covered in the Equine Chorionic Gonadotropin (eCG) for Injection Market report?

Ans: The Types covered in the Equine Chorionic Gonadotropin (eCG) for Injection Market report are 1000 IU/Unit, 5000 IU/Unit, Others

1 Equine Chorionic Gonadotropin (eCG) for Injection Market Overview
1.1 Product Definition
1.2 Equine Chorionic Gonadotropin (eCG) for Injection by Type
1.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Type: 2025 vs 2032
1.2.2 1000 IU/Unit
1.2.3 5000 IU/Unit
1.2.4 Others
1.3 Equine Chorionic Gonadotropin (eCG) for Injection by Application
1.3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Application: 2025 vs 2032
1.3.2 Pig
1.3.3 Cattle
1.3.4 Sheep
1.3.5 Horse
1.3.6 Other Animals
1.4 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Estimates and Forecasts
1.4.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2021–2032
1.4.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales 2021–2032
1.4.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Equine Chorionic Gonadotropin (eCG) for Injection Market Competition by Manufacturers
2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Equine Chorionic Gonadotropin (eCG) for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Date of Entry into the Industry
2.8 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Competitive Situation and Trends
2.8.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Equine Chorionic Gonadotropin (eCG) for Injection Players Market Share by Revenue
2.8.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Scenario by Region
3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region: 2021–2032
3.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region: 2021–2026
3.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region: 2027–2032
3.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2021–2032
3.3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2021–2026
3.3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2027–2032
3.4 North America Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.4.1 North America Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2021–2032)
3.4.3 North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.5.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2021–2032)
3.5.3 Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.7.1 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2021–2032)
3.7.3 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2021–2032)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2021–2026)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2027–2032)
4.1.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2021–2032)
4.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2021–2032)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2021–2026)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2027–2032)
4.2.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2021–2032)
5.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2021–2026)
5.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2027–2032)
5.1.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2021–2032)
5.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2021–2032)
5.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2021–2026)
5.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2027–2032)
5.2.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Ceva Santé Animale
6.2.1 Ceva Santé Animale Company Information
6.2.2 Ceva Santé Animale Description and Business Overview
6.2.3 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.2.5 Ceva Santé Animale Recent Developments/Updates
6.3 Syntex SA
6.3.1 Syntex SA Company Information
6.3.2 Syntex SA Description and Business Overview
6.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.3.5 Syntex SA Recent Developments/Updates
6.4 Bioveta
6.4.1 Bioveta Company Information
6.4.2 Bioveta Description and Business Overview
6.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.4.5 Bioveta Recent Developments/Updates
6.5 Ningbo Sansheng Biological Technology
6.5.1 Ningbo Sansheng Biological Technology Company Information
6.5.2 Ningbo Sansheng Biological Technology Description and Business Overview
6.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.5.5 Ningbo Sansheng Biological Technology Recent Developments/Updates
6.6 Ningbo Second Hormone Factory
6.6.1 Ningbo Second Hormone Factory Company Information
6.6.2 Ningbo Second Hormone Factory Description and Business Overview
6.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.6.5 Ningbo Second Hormone Factory Recent Developments/Updates
6.7 Chifeng Bo-en Pharmaceutical
6.7.1 Chifeng Bo-en Pharmaceutical Company Information
6.7.2 Chifeng Bo-en Pharmaceutical Description and Business Overview
6.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.7.5 Chifeng Bo-en Pharmaceutical Recent Developments/Updates
6.8 Guangzhou Vbio-Pharma
6.8.1 Guangzhou Vbio-Pharma Company Information
6.8.2 Guangzhou Vbio-Pharma Description and Business Overview
6.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.8.5 Guangzhou Vbio-Pharma Recent Developments/Updates
6.9 JALLY
6.9.1 JALLY Company Information
6.9.2 JALLY Description and Business Overview
6.9.3 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.9.5 JALLY Recent Developments/Updates
6.10 Ningbo Creator Animal Pharmaceutical
6.10.1 Ningbo Creator Animal Pharmaceutical Company Information
6.10.2 Ningbo Creator Animal Pharmaceutical Description and Business Overview
6.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.10.5 Ningbo Creator Animal Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Chorionic Gonadotropin (eCG) for Injection Industry Chain Analysis
7.2 Equine Chorionic Gonadotropin (eCG) for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Chorionic Gonadotropin (eCG) for Injection Production Mode & Process Analysis
7.4 Equine Chorionic Gonadotropin (eCG) for Injection Sales and Marketing
7.4.1 Equine Chorionic Gonadotropin (eCG) for Injection Sales Channels
7.4.2 Equine Chorionic Gonadotropin (eCG) for Injection Distributors
7.5 Equine Chorionic Gonadotropin (eCG) for Injection Customer Analysis
8 Equine Chorionic Gonadotropin (eCG) for Injection Market Dynamics
8.1 Equine Chorionic Gonadotropin (eCG) for Injection Industry Trends
8.2 Equine Chorionic Gonadotropin (eCG) for Injection Market Drivers
8.3 Equine Chorionic Gonadotropin (eCG) for Injection Market Challenges
8.4 Equine Chorionic Gonadotropin (eCG) for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Equine Chorionic Gonadotropin (eCG) for Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Equine Chorionic Gonadotropin (eCG) for Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Equine Chorionic Gonadotropin (eCG) for Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. MSD Animal Health Company Information
 Table 71. MSD Animal Health Description and Business Overview
 Table 72. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 74. MSD Animal Health Recent Developments/Updates
 Table 75. Ceva Santé Animale Company Information
 Table 76. Ceva Santé Animale Description and Business Overview
 Table 77. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 79. Ceva Santé Animale Recent Developments/Updates
 Table 80. Syntex SA Company Information
 Table 81. Syntex SA Description and Business Overview
 Table 82. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 84. Syntex SA Recent Developments/Updates
 Table 85. Bioveta Company Information
 Table 86. Bioveta Description and Business Overview
 Table 87. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 89. Bioveta Recent Developments/Updates
 Table 90. Ningbo Sansheng Biological Technology Company Information
 Table 91. Ningbo Sansheng Biological Technology Description and Business Overview
 Table 92. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 94. Ningbo Sansheng Biological Technology Recent Developments/Updates
 Table 95. Ningbo Second Hormone Factory Company Information
 Table 96. Ningbo Second Hormone Factory Description and Business Overview
 Table 97. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 99. Ningbo Second Hormone Factory Recent Developments/Updates
 Table 100. Chifeng Bo-en Pharmaceutical Company Information
 Table 101. Chifeng Bo-en Pharmaceutical Description and Business Overview
 Table 102. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 104. Chifeng Bo-en Pharmaceutical Recent Developments/Updates
 Table 105. Guangzhou Vbio-Pharma Company Information
 Table 106. Guangzhou Vbio-Pharma Description and Business Overview
 Table 107. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 109. Guangzhou Vbio-Pharma Recent Developments/Updates
 Table 110. JALLY Company Information
 Table 111. JALLY Description and Business Overview
 Table 112. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 114. JALLY Recent Developments/Updates
 Table 115. Ningbo Creator Animal Pharmaceutical Company Information
 Table 116. Ningbo Creator Animal Pharmaceutical Description and Business Overview
 Table 117. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product
 Table 119. Ningbo Creator Animal Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Equine Chorionic Gonadotropin (eCG) for Injection Distributors List
 Table 123. Equine Chorionic Gonadotropin (eCG) for Injection Customers List
 Table 124. Equine Chorionic Gonadotropin (eCG) for Injection Market Trends
 Table 125. Equine Chorionic Gonadotropin (eCG) for Injection Market Drivers
 Table 126. Equine Chorionic Gonadotropin (eCG) for Injection Market Challenges
 Table 127. Equine Chorionic Gonadotropin (eCG) for Injection Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Equine Chorionic Gonadotropin (eCG) for Injection
 Figure 2. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Type: 2025 & 2032
 Figure 4. 1000 IU/Unit Product Picture
 Figure 5. 5000 IU/Unit Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Application: 2025 & 2032
 Figure 9. Pig
 Figure 10. Cattle
 Figure 11. Sheep
 Figure 12. Horse
 Figure 13. Other Animals
 Figure 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (US$ Million), 2021–2032
 Figure 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), 2021–2032
 Figure 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Average Price (US$/Unit), 2021–2032
 Figure 18. Equine Chorionic Gonadotropin (eCG) for Injection Report Years Considered
 Figure 19. Equine Chorionic Gonadotropin (eCG) for Injection Sales Share by Manufacturers in 2025
 Figure 20. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Equine Chorionic Gonadotropin (eCG) for Injection Players: Market Share by Revenue in Equine Chorionic Gonadotropin (eCG) for Injection in 2025
 Figure 22. Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2021–2032)
 Figure 25. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2021–2032)
 Figure 26. United States Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2021–2032)
 Figure 29. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2021–2032)
 Figure 37. China Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2021–2032)
 Figure 57. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Application (2021–2032)
 Figure 60. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Application (2021–2032)
 Figure 61. Equine Chorionic Gonadotropin (eCG) for Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture